ProShares Ultra Health Care (RXL) seeks to deliver twice (2x) the daily performance of the Dow Jones U.S. Health Care Index, which measures the investment return of U.S. healthcare companies including pharmaceuticals, biotechnology, medical devices, and healthcare services providers.
How It Works
RXL uses derivatives including swaps and futures contracts to achieve 200% daily exposure to its underlying healthcare index. The fund rebalances daily to maintain its 2x leverage target, meaning it seeks 2% gains when healthcare stocks rise 1% and 2% losses when they fall 1%. This mathematical reset occurs every trading day regardless of market direction, creating compounding effects over multiple days that cause returns to deviate significantly from simply doubling the index's multi-day performance.
Key Features
- Provides 2x daily exposure to healthcare sector, amplifying both gains and losses for tactical trading strategies
- Daily rebalancing maintains precise leverage but creates compounding effects unsuitable for buy-and-hold investing
- Focuses on established healthcare companies rather than speculative biotech, offering leveraged exposure to defensive sector
Risks
- Daily reset causes compounding decay—if healthcare drops 10% then rises 10%, this ETF does NOT return to break-even due to mathematical effects of percentage changes
- Leverage amplifies all movements, so 20% healthcare sector declines become 40% losses, potentially occurring within single trading sessions during market stress
- Healthcare sector faces regulatory risks from drug pricing policies, FDA approvals, and healthcare reform that can trigger sudden sector-wide selloffs
Who Should Own This
Designed exclusively for active traders with high risk tolerance seeking short-term (hours to days) tactical exposure to healthcare sector momentum. Requires daily monitoring and strict position sizing (maximum 5-10% of portfolio). Completely unsuitable for retirement accounts or buy-and-hold strategies due to compounding decay over time.